176 related articles for article (PubMed ID: 32595499)
1. Treatment of Experimental Cerebral Malaria by Slow Release of Artemisone From Injectable Pasty Formulation.
Golenser J; Salaymeh N; Higazi AA; Alyan M; Daif M; Dzikowski R; Domb AJ
Front Pharmacol; 2020; 11():846. PubMed ID: 32595499
[TBL] [Abstract][Full Text] [Related]
2. Controlled release of artemisone for the treatment of experimental cerebral malaria.
Golenser J; Buchholz V; Bagheri A; Nasereddin A; Dzikowski R; Guo J; Hunt NH; Eyal S; Vakruk N; Greiner A
Parasit Vectors; 2017 Mar; 10(1):117. PubMed ID: 28249591
[TBL] [Abstract][Full Text] [Related]
3. Treatment of murine cerebral malaria by artemisone in combination with conventional antimalarial drugs: antiplasmodial effects and immune responses.
Guiguemde WA; Hunt NH; Guo J; Marciano A; Haynes RK; Clark J; Guy RK; Golenser J
Antimicrob Agents Chemother; 2014 Aug; 58(8):4745-54. PubMed ID: 24913162
[TBL] [Abstract][Full Text] [Related]
4. Artemisone effective against murine cerebral malaria.
Waknine-Grinberg JH; Hunt N; Bentura-Marciano A; McQuillan JA; Chan HW; Chan WC; Barenholz Y; Haynes RK; Golenser J
Malar J; 2010 Aug; 9():227. PubMed ID: 20691118
[TBL] [Abstract][Full Text] [Related]
5. Elimination of Schistosoma mansoni in infected mice by slow release of artemisone.
Gold D; Alian M; Domb A; Karawani Y; Jbarien M; Chollet J; Haynes RK; Wong HN; Buchholz V; Greiner A; Golenser J
Int J Parasitol Drugs Drug Resist; 2017 Aug; 7(2):241-247. PubMed ID: 28511056
[TBL] [Abstract][Full Text] [Related]
6. Glucocorticosteroids in nano-sterically stabilized liposomes are efficacious for elimination of the acute symptoms of experimental cerebral malaria.
Waknine-Grinberg JH; Even-Chen S; Avichzer J; Turjeman K; Bentura-Marciano A; Haynes RK; Weiss L; Allon N; Ovadia H; Golenser J; Barenholz Y
PLoS One; 2013; 8(8):e72722. PubMed ID: 23991146
[TBL] [Abstract][Full Text] [Related]
7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
8. Transdermal delivery of artemisinins for treatment of pre-clinical cerebral malaria.
Zech J; Dzikowski R; Simantov K; Golenser J; Mäder K
Int J Parasitol Drugs Drug Resist; 2021 Aug; 16():148-154. PubMed ID: 34116478
[TBL] [Abstract][Full Text] [Related]
9. Cysteamine broadly improves the anti-plasmodial activity of artemisinins against murine blood stage and cerebral malaria.
Moradin N; Torre S; Gauthier S; Tam M; Hawari J; Vandercruyssen K; De Spiegeleer B; Fortin A; Stevenson MM; Gros P
Malar J; 2016 May; 15(1):260. PubMed ID: 27150250
[TBL] [Abstract][Full Text] [Related]
10. UK malaria treatment guidelines 2016.
Lalloo DG; Shingadia D; Bell DJ; Beeching NJ; Whitty CJM; Chiodini PL;
J Infect; 2016 Jun; 72(6):635-649. PubMed ID: 26880088
[TBL] [Abstract][Full Text] [Related]
11. Oral Therapy Using a Combination of Nanotized Antimalarials and Immunomodulatory Molecules Reduces Inflammation and Prevents Parasite Induced Pathology in the Brain and Spleen of
Mukherjee S; Ray G; Saha B; Kar SK
Front Immunol; 2021; 12():819469. PubMed ID: 35095923
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of artemiside and its effects in combination with conventional drugs against severe murine malaria.
Guo J; Guiguemde AW; Bentura-Marciano A; Clark J; Haynes RK; Chan WC; Wong HN; Hunt NH; Guy RK; Golenser J
Antimicrob Agents Chemother; 2012 Jan; 56(1):163-73. PubMed ID: 22006004
[TBL] [Abstract][Full Text] [Related]
13. Antimalarial efficacy and drug interactions of the novel semi-synthetic endoperoxide artemisone in vitro and in vivo.
Vivas L; Rattray L; Stewart LB; Robinson BL; Fugmann B; Haynes RK; Peters W; Croft SL
J Antimicrob Chemother; 2007 Apr; 59(4):658-65. PubMed ID: 17337512
[TBL] [Abstract][Full Text] [Related]
14. The Artemiside-Artemisox-Artemisone-M1 Tetrad: Efficacies against Blood Stage
Gibhard L; Coertzen D; Reader J; van der Watt ME; Birkholtz LM; Wong HN; Batty KT; Haynes RK; Wiesner L
Pharmaceutics; 2021 Dec; 13(12):. PubMed ID: 34959347
[TBL] [Abstract][Full Text] [Related]
15. Assessment of the induction of dormant ring stages in Plasmodium falciparum parasites by artemisone and artemisone entrapped in Pheroid vesicles in vitro.
Grobler L; Chavchich M; Haynes RK; Edstein MD; Grobler AF
Antimicrob Agents Chemother; 2014 Dec; 58(12):7579-82. PubMed ID: 25288088
[TBL] [Abstract][Full Text] [Related]
16. UK malaria treatment guidelines.
Lalloo DG; Shingadia D; Pasvol G; Chiodini PL; Whitty CJ; Beeching NJ; Hill DR; Warrell DA; Bannister BA;
J Infect; 2007 Feb; 54(2):111-21. PubMed ID: 17215045
[TBL] [Abstract][Full Text] [Related]
17. Lambda-carrageenan treatment exacerbates the severity of cerebral malaria caused by Plasmodium berghei ANKA in BALB/c mice.
Recuenco FC; Takano R; Chiba S; Sugi T; Takemae H; Murakoshi F; Ishiwa A; Inomata A; Horimoto T; Kobayashi Y; Horiuchi N; Kato K
Malar J; 2014 Dec; 13():487. PubMed ID: 25495520
[TBL] [Abstract][Full Text] [Related]
18. Optimal 10-Aminoartemisinins With Potent Transmission-Blocking Capabilities for New Artemisinin Combination Therapies-Activities Against Blood Stage
Wong HN; Padín-Irizarry V; van der Watt ME; Reader J; Liebenberg W; Wiesner L; Smith P; Eribez K; Winzeler EA; Kyle DE; Birkholtz LM; Coertzen D; Haynes RK
Front Chem; 2019; 7():901. PubMed ID: 31998692
[TBL] [Abstract][Full Text] [Related]
19. Artemisone uptake in Plasmodium falciparum-infected erythrocytes.
Pooley S; Fatih FA; Krishna S; Gerisch M; Haynes RK; Wong HN; Staines HM
Antimicrob Agents Chemother; 2011 Feb; 55(2):550-6. PubMed ID: 21135191
[TBL] [Abstract][Full Text] [Related]
20. First assessment in humans of the safety, tolerability, pharmacokinetics, and ex vivo pharmacodynamic antimalarial activity of the new artemisinin derivative artemisone.
Nagelschmitz J; Voith B; Wensing G; Roemer A; Fugmann B; Haynes RK; Kotecka BM; Rieckmann KH; Edstein MD
Antimicrob Agents Chemother; 2008 Sep; 52(9):3085-91. PubMed ID: 18559649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
